Skip to main content

New Products

  • Ginger Ale a favorite among flavored CSDs

    PLANO, Texas — Canada Dry Ginger Ale has long been a staple in the flavored soft drink category. The brand, invented by a pharmacist in 1904, has seen an uptick in sales that Dr Pepper Snapple Group attributes to “the perceived healthfulness of ginger ale as a CSD flavor.” Sales were up 20% in the drug store channel last year, according to Nielsen.

  • Sun Pharma approved for generic Temodar

    MUMBAI — Sun Pharmaceutical Industries announced that the Food and Drug Administration has granted final approval for its generic version of Temodar temozolomide capsules in 5-mg, 20-mg, 100-mg 140-mg, 180-mg and 250-mg form.

  • Report: Florida lawmakers eye telemedicine

    NEW YORK — Lawmakers in Florida are looking into ways to ease regulatory limitations for telemedicine in an effort to increase access to care and create “a fertile ground” for the technology to be used, according to a local report.

  • New device aims to keep Rx drugs out of the 'wrong hands'

    NOVATO, Calif. — 4ThoughtProducts has announced the release of Pill Pod, a new safety device that serves as a "keyless" drug lock box for use in the home.

  • Jelly Belly adds more Camo

    FAIRFIELD, Calif — Jelly Belly Candy Co. recently introduced a line of Camo Beans, which include beans inspired by the art of camouflage. On Wednesday, the company announced that it’s introducing Pink Camo beans to the mix.

    The new Pink Camo Beans collection is comprised of flavors like Cotton Candy, Coconut, Licorice, Cherry Passion Fruit Smoothie, Bubble Gum and Strawberry Cheesecake.

  • Alberto V05 introduces new Men's 3-in-1

    STAMFORD, Conn. — The Alberto VO5 brand, which is owned by High Ridge Brands, has introduced its new VO5 Men's 3-in-1, combining VO5 shampoo, conditioner and body wash.  

  • Janssen Biotech: Second indication won for cancer drug Imbruvica

    HORSHAM, Pa. — Janssen Biotech on Wednesday announced the Food and Drug Administration has approved Imbruvica (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia who have received at least one prior therapy. Imbruvica was first approved in November 2013 for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Both indications are based on an overall response rate. An improvement in survival or disease-related symptoms has not been established.

  • Merz North America launches Mederma PM

    GREENSBORO, N.C. — Merz North America recently launched Mederma PM, a new one-of-a-kind scar cream formulated to work at night, when skin naturally regenerates faster.  

    Mederma PM Intensive Overnight Scar Cream is formulated to complement this nighttime activity with Tripeptol, a skin-nourishing complex with peptides, collagen and antioxidants to promote healthy-looking skin and help skin fight free radical damage. 

X
This ad will auto-close in 10 seconds